Alambic Investment Management, L.P. - KALA PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 102 filers reported holding KALA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.

Filings

EDGAR links

External links

Quarter-by-quarter ownership

Alambic Investment Management, L.P. ownership history of KALA PHARMACEUTICALS INC
	Value		Shares		Weighting
Q4 2019	$40,000	-38.5%	10,787	-36.8%	0.03%	-32.7%
Q3 2019	$65,000	-88.2%	17,072	-80.3%	0.05%	-85.6%
Q2 2019	$552,000	+60.5%	86,487	+108.0%	0.34%	+141.8%
Q1 2019	$344,000	–	41,588	–	0.14%	–
Download

Other shareholders

KALA PHARMACEUTICALS INC shareholders Q1 2020
Name	Shares	Value	Weighting ↓
Vahanian & Associates Financial Planning Inc.	181,384	$54,000	0.23%
Samsara BioCapital, LLC	601,162	$180,000	0.05%
Board of Trustees of The Leland Stanford Junior University	688,701	$207,000	0.01%
Matisse Capital	36,800	$11,000	0.01%
Knights of Columbus Asset Advisors LLC	120,841	$36,000	0.00%
Covestor Ltd	11,972	$4,000	0.00%
Ergoteles LLC	219,461	$66,000	0.00%
Virtu Financial LLC	74,636	$22,000	0.00%
Banque Cantonale Vaudoise	75,420	$23,000	0.00%
GSA CAPITAL PARTNERS LLP	12,975	$4,000	0.00%

View complete list of KALA PHARMACEUTICALS INC shareholders